Evidence map›Paper›PMID 40385458›Full record

ArticleUrology case reports2025

Prostatic cancer with parotid metastases.

Hanane Inrhaoun, Ibrahim Elghissassi, Sara Naciri, Salma Najem, Sihame Lkhoyaali, Ahmed Ibrahimi, Tsioukaka Gray, Rachida Latib, Saber Boutayeb, Hind Mrabti and 1 more

Abstract readCase Reports
In one paragraph

Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hanane InrhaounMedical Oncology Department, National Institute of Oncology, Rabat, Morocco.
Ibrahim ElghissassiMedical Oncology Department, National Institute of Oncology, Rabat, Morocco.
Sara NaciriMedical Oncology Department, National Institute of Oncology, Rabat, Morocco.
Salma NajemMedical Oncology Department, National Institute of Oncology, Rabat, Morocco.
Sihame LkhoyaaliMedical Oncology Department, National Institute of Oncology, Rabat, Morocco.
Ahmed IbrahimiUrology Department, Ibn Sina Hospital, Rabat, Morocco.
Tsioukaka GrayRadiology Department, National Institute of Oncology, Rabat, Morocco.
Rachida LatibRadiology Department, National Institute of Oncology, Rabat, Morocco.
Saber BoutayebMedical Oncology Department, National Institute of Oncology, Rabat, Morocco.
Hind MrabtiMedical Oncology Department, National Institute of Oncology, Rabat, Morocco.
Hassan ErrihaniMedical Oncology Department, National Institute of Oncology, Rabat, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parotid metastases from prostate cancer are unusual. The distinction between a primary parotid neoplasm and a metastasis is important clinically, because the management of metastasis in castration resistant prostate cancer is different. We report a rare case of a 75 years old man, who presented a parotid metastasis from a primary prostate cancer.

Identifiers

PMID40385458
PMCPMC12084405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.